Literature DB >> 7824539

Anxiolytic-like effect of paroxetine in a rat social interaction test.

S Lightowler1, G A Kennett, I J Williamson, T P Blackburn, I F Tulloch.   

Abstract

The effects of short- and long-term administration of the selective serotonin reuptake inhibitor paroxetine were investigated in a rat social interaction test. A single administration of paroxetine at oral doses of 0.3, 1, 3 and 10 mg/kg had no effect on social interaction between pairs of male rats under bright light (high anxiety) conditions. After 21 days of daily administration, paroxetine given orally at 3 mg/kg significantly (p < 0.01) increased the time spent in social interaction by pairs of rats tested under the same conditions, with no effect on locomotor activity, indicating an anxiolytic-like effect. The magnitude of increase (+97%) was comparable to that seen after a single dose of chlordiazepoxide (4 mg/kg orally). Although there was also an increase in time spent in social interaction after 21 days of repeated oral administration of paroxetine at 0.3, 1, and 10 mg/kg (+44, +56, and +54% increases, respectively), statistical significance was not achieved. These results indicate that in the long term paroxetine has an anxiolytic action, and thus support the clinical evidence for its therapeutic use in the treatment of anxiety disorders in addition to its established role as an antidepressant.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824539     DOI: 10.1016/0091-3057(94)90422-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  22 in total

Review 1.  Toward an integrative understanding of social phobia.

Authors:  D Li; P Chokka; P Tibbo
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Stress sensitization of ethanol withdrawal-induced reduction in social interaction: inhibition by CRF-1 and benzodiazepine receptor antagonists and a 5-HT1A-receptor agonist.

Authors:  George R Breese; Darin J Knapp; David H Overstreet
Journal:  Neuropsychopharmacology       Date:  2004-03       Impact factor: 7.853

3.  Social approach-avoidance behavior of a high-anxiety strain of rats: effects of benzodiazepine receptor ligands.

Authors:  Laurent B Nicolas; Eric P M Prinssen
Journal:  Psychopharmacology (Berl)       Date:  2005-12-03       Impact factor: 4.530

Review 4.  Assessing behavioural and cognitive domains of autism spectrum disorders in rodents: current status and future perspectives.

Authors:  Martien J Kas; Jeffrey C Glennon; Jan Buitelaar; Elodie Ey; Barbara Biemans; Jacqueline Crawley; Robert H Ring; Clara Lajonchere; Frederic Esclassan; John Talpos; Lucas P J J Noldus; J Peter H Burbach; Thomas Steckler
Journal:  Psychopharmacology (Berl)       Date:  2013-09-19       Impact factor: 4.530

5.  Pharmacological depletion of serotonin in the basolateral amygdala complex reduces anxiety and disrupts fear conditioning.

Authors:  Philip L Johnson; Andrei Molosh; Stephanie D Fitz; Dave Arendt; Gerald A Deehan; Lauren M Federici; Cristian Bernabe; Eric A Engleman; Zachary A Rodd; Christopher A Lowry; Anantha Shekhar
Journal:  Pharmacol Biochem Behav       Date:  2015-11       Impact factor: 3.533

6.  Cerebral tryptophan hydroxylase activity, and 5-HT1A receptor, 5-HT2A receptor, and 5-HT transporter binding in grouped and isolated Roman RHA and RLA rats: relationships with behaviours in two models of anxiety.

Authors:  A Kulikov; N Castanon; P Mormède; F Chaouloff
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

Review 7.  Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.

Authors:  Toshiharu Shimazaki; Takao Yoshimizu; Shigeyuki Chaki
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

8.  Similar anxiety-like responses in male and female rats exposed to repeated withdrawals from ethanol.

Authors:  David H Overstreet; Darin J Knapp; George R Breese
Journal:  Pharmacol Biochem Behav       Date:  2004-07       Impact factor: 3.533

9.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

10.  Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors.

Authors:  David H Overstreet; Darin J Knapp; George R Breese
Journal:  Pharmacol Biochem Behav       Date:  2004-02       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.